首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trials
Authors:R.G. Langley  A.W. Armstrong  M.G. Lebwohl  A. Blauvelt  S. Hsu  S. Tyring  S. Rastogi  R. Pillai  R. Israel
Affiliation:1. Dalhousie University, Halifax, NS, Canada;2. University of Southern California, Los Angeles, CA, U.S.A;3. Icahn School of Medicine at Mount Sinai, New York, NY, U.S.A;4. Oregon Medical Research Center, Portland, OR, U.S.A;5. Temple University School of Medicine, Philadelphia, PA, U.S.A;6. University of Texas Health Science Center, Houston, TX, U.S.A;7. Ortho Dermatologics, Bridgewater, NJ, U.S.A;8. Dow Pharmaceutical Sciences, Petaluma, CA, U.S.A;9. Valeant Pharmaceuticals North America LLC, Bridgewater, NJ, U.S.A
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号